CSPC Innovation Pharmaceutical Swings to Q1 Loss

MT Newswires07:38 ET

Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.

① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?

cls.cn03:37 ET

CSPC PHARMA (01093): CSPC's innovative Q1 parent net loss of 26.9016 million yuan.

CSPC PHARMA (01093) announced that its subsidiary CSPC Innovative Pharmaceuticals Co., Ltd. (CSPC Innovative) has ...

Zhitong FinanceApr 23 08:17 ET

CSPC PHARMA: UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2025

HKEXApr 23 08:09 ET · Announcements

CSPC Pharmaceutical Gets FDA Nod for Cancer Cachexia Drug Trial

MT NewswiresApr 23 05:49 ET

Hong Kong stock movement | CSPC PHARMA (01093) rises more than 3% again, approval received for clinical trial of Ploglitazone Metformin Extended-Release Tablets.

CSPC PHARMA (01093) rose over 3% again, as of the time of writing, it increased by 3.31%, priced at 6.25 HKD, with a transaction volume of 0.654 billion HKD.

Zhitong FinanceApr 22 23:26 ET